Author of

• 11946

  +

  P2.24 - Poster Session 2 - Supportive Care (ID 157)

  • Event: WCLC 2013
  • Type: Poster Session
  • Track: Supportive Care
  • Presentations: 1
  • Moderators:
  • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level

  • 11954

    +

    P2.24-008 - eviQ - a web based, point of care treatment resource - its role in lung cancer (ID 828)

    09:30 - 09:30  |  Author(s): L. King
    • Abstract

    Background
    eviQ Cancer Treatments Online, launched in October 2009, is a Cancer Institute NSW flagship program. Its primary remit is to improve service delivery, standardise cancer treatment and improve patient outcomes. The primary audience is health professionals involved in delivering cancer care. Tailored information is also available for people with cancer and their carers, and other non-cancer health professionals. This open-access, web-based repository provides approximately 600 peer-reviewed cancer treatment protocols designed to support the way in which cancer care is implemented. eviQ treatment protocols and nursing resources provide detailed and extensive instructions on how to deliver evidence-based cancer treatments safely and appropriately. Provision of eviQ information promotes equity of access to the same information across rural, remote and metropolitan settings. eviQ provides reference standards that support the measurement and reporting of cancer treatment delivery to further determine strategies to reduce variation and improve patient outcomes.

    Methods
    Treatment protocols are developed according to the eviQ Governance Framework. Content specific reference committees, made up of clinical experts, discuss and review protocols at face to face meetings, and endorse them for publication on the site. Content is reviewed and updated in accordance with strict risk stratification criteria. This work is underpinned by the use of a tailor-made bibliometrics system, ensuring that the latest published evidence drives protocol development.

    Results
    eviQ includes a mechanism to record de-identified usage of the website. Usage has increased significantly; from 1932 in December 2009 to 27,853 (2,386 international) registered users in May 2013. Registered users by primary role: Australia (+ international) Medical 4,192 (+ 536) Nursing 11,377 (+653) Radiation therapy 1,031(+185) Allied Health 840 (+38) Other 4,889 (+486) There are currently 31 chemotherapy and 7 radiation respiratory cancer treatment protocols available on the site which were last reviewed and updated in 2012. The most frequently accessed respiratory treatment protocols (NSCLC carboplatin & gemcitabine and SCLC cisplatin & etoposide) are visited on average over 1000 times per month (based on figures from 2012-2013), this being comparable to similar breast treatment protocols (adjuvant adriamycin & paclitaxel and docetaxel & cyclophosphamide). Statistics confirm eviQ is accessed by a wide range of users in both public and private health care settings. eviQ is utilised in the tertiary setting as a teaching tool, further embedding the use of evidence based practice in the clinical setting. Independent evaluation undertaken in 2012 concluded eviQ is an easily usable, quality resource that supports evidence based practice in cancer care.

    Conclusion
    Every health professional engaged in cancer care has a responsibility to ensure work practice systems are optimised to ensure best patient outcomes. As a unique evidence- based online resource, eviQ contributes to reducing this variability. By harnessing the collective expertise of health care professionals in Australia, eviQ has developed an efficient, safe, quality national resource of evidence-based cancer treatment information for use at the point of care.